ATE371667T1 - Kahalalide f und verwandte verbindungen - Google Patents

Kahalalide f und verwandte verbindungen

Info

Publication number
ATE371667T1
ATE371667T1 AT01904169T AT01904169T ATE371667T1 AT E371667 T1 ATE371667 T1 AT E371667T1 AT 01904169 T AT01904169 T AT 01904169T AT 01904169 T AT01904169 T AT 01904169T AT E371667 T1 ATE371667 T1 AT E371667T1
Authority
AT
Austria
Prior art keywords
kahalalide
related compounds
leads
preparing
biological activity
Prior art date
Application number
AT01904169T
Other languages
English (en)
Inventor
Fernando Albericio
Ernest Giralt
Jose Jimenez
Angel Lopez
Ignacio Manzanares
Ignacio Rodrigues
Miriam Royo
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of ATE371667T1 publication Critical patent/ATE371667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Detergent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AT01904169T 2000-02-09 2001-02-09 Kahalalide f und verwandte verbindungen ATE371667T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0002952.0A GB0002952D0 (en) 2000-02-09 2000-02-09 Process for producing kahalalide F compounds

Publications (1)

Publication Number Publication Date
ATE371667T1 true ATE371667T1 (de) 2007-09-15

Family

ID=9885232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01904169T ATE371667T1 (de) 2000-02-09 2001-02-09 Kahalalide f und verwandte verbindungen

Country Status (28)

Country Link
US (2) US7482429B2 (de)
EP (3) EP1254162B1 (de)
JP (1) JP5188665B2 (de)
KR (1) KR100871489B1 (de)
CN (2) CN101597326B (de)
AT (1) ATE371667T1 (de)
AU (1) AU783542B2 (de)
BG (1) BG65926B1 (de)
BR (1) BR0108213A (de)
CA (1) CA2399187C (de)
CY (1) CY1106992T1 (de)
CZ (1) CZ304258B6 (de)
DE (1) DE60130192T2 (de)
DK (1) DK1254162T3 (de)
ES (1) ES2292558T3 (de)
GB (1) GB0002952D0 (de)
HK (1) HK1047290A1 (de)
HU (1) HUP0301817A3 (de)
IL (2) IL150981A0 (de)
MX (1) MXPA02007760A (de)
NO (1) NO331847B1 (de)
NZ (1) NZ520488A (de)
PL (1) PL207121B1 (de)
PT (1) PT1254162E (de)
RU (1) RU2280039C2 (de)
SK (1) SK11242002A3 (de)
UA (1) UA76949C2 (de)
WO (1) WO2001058934A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
SK286421B6 (sk) 2000-10-31 2008-09-05 Pharma Mar, S. A. Prostriedok kahalalid F, súprava, rekonštituovanýa zriedený roztok s obsahom tohto prostriedku a použitie
US20050054555A1 (en) * 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) * 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
GB0408958D0 (en) * 2004-04-22 2004-05-26 Pharma Mar Sa Convergent synthesis for kahalalide compounds
CN100396696C (zh) * 2004-04-23 2008-06-25 中国科学院海洋研究所 一种海洋绿藻在提取抗肿瘤活性环肽组分中的应用
RU2010119922A (ru) * 2007-10-19 2011-11-27 Фарма Мар, С.А. (Es) Усовершенствованное противоопухолевое лечение
WO2009095480A1 (en) * 2008-01-30 2009-08-06 Pharma Mar, S.A. Improved antitumoral treatments
EP2262522A1 (de) * 2008-03-07 2010-12-22 Pharma Mar, S.A. Verbesserte antitumorale behandlungen
CN103641891B (zh) * 2013-05-23 2017-03-22 深圳翰宇药业股份有限公司 一种制备Kahalalide F的方法
KR102279993B1 (ko) 2015-09-23 2021-07-21 엑스더블유파마 리미티드 감마-하이드록시부티르산의 전구체 및 이의 조성물 및 용도
JP6991239B2 (ja) 2017-03-30 2022-01-12 エックスダブリューファルマ リミテッド 二環式ヘテロアリール誘導体ならびにその調製および使用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
WO2020062251A1 (en) 2018-09-30 2020-04-02 Xw Laboratories, Inc. Compounds as neuronal histamine receptor-3 antagonists and uses thereof
CA3162919A1 (en) 2019-12-20 2021-06-24 XWPharma Ltd. Methods of synthesizing 4-valyloxybutyric acid
CN115038432B (zh) 2020-06-18 2023-12-26 凯瑞康宁生物工程（武汉）有限公司 水溶性活性药物成分的控制释放制粒
JP2023537192A (ja) 2020-06-18 2023-08-31 エックスダブリューファーマ リミテッド 水溶性医薬品有効成分の医薬造粒物
US11896573B2 (en) 2020-07-24 2024-02-13 XWPharma Ltd. Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative
WO2022076466A1 (en) 2020-10-05 2022-04-14 XWPharma Ltd. Modified release compositions of a gamma-hydroxybutyric acid derivative
US11510892B2 (en) 2021-03-19 2022-11-29 XWPharma Ltd. Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative
US20230382880A1 (en) * 2022-04-21 2023-11-30 Zevra Therapeutics, Inc. Gamma-hydroxybutyrate delivering compounds and processes for making and using them

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US39496A (en) * 1863-08-11 Improvement in ratchet-drills
CU22545A1 (es) * 1994-11-18 1999-03-31 Centro Inmunologia Molecular Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
JPS6178719A (ja) 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
ES2204890T3 (es) * 1991-03-06 2004-05-01 Merck Patent Gmbh Anticuerpos monoclonales humanizados.
US5849704A (en) 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
GB9302046D0 (en) * 1993-02-03 1993-03-24 Pharma Mar Sa Antiumoral compound-v
US6274551B1 (en) * 1994-02-03 2001-08-14 Pharmamar, S.A. Cytotoxic and antiviral compound
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US5705511A (en) 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US5747498A (en) * 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
ID19609A (id) * 1996-07-13 1998-07-23 Glaxo Group Ltd Senyawa-senyawa heterosiklik
US6235883B1 (en) * 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
WO1998050406A1 (en) * 1997-05-09 1998-11-12 The General Hospital Corporation Cell proliferation related genes
RS49779B (sr) * 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
US6200598B1 (en) * 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
EA003786B1 (ru) * 1998-11-19 2003-10-30 Варнер Ламберт Компани N-[4-(3-хлор-4-фторфениламино)-7-(3-морфолин-4-илпропокси)хиназолин-6-ил]акриламид - необратимый ингибитор тирозинкиназ
US7311924B2 (en) * 1999-04-01 2007-12-25 Hana Biosciences, Inc. Compositions and methods for treating cancer
UA74803C2 (uk) * 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
WO2001083692A2 (en) * 2000-04-28 2001-11-08 The Trustees Of The University Of Pennsylvania Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
SK286421B6 (sk) 2000-10-31 2008-09-05 Pharma Mar, S. A. Prostriedok kahalalid F, súprava, rekonštituovanýa zriedený roztok s obsahom tohto prostriedku a použitie
US20050054555A1 (en) 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) * 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
GB0408958D0 (en) * 2004-04-22 2004-05-26 Pharma Mar Sa Convergent synthesis for kahalalide compounds

Also Published As

Publication number Publication date
JP2003522198A (ja) 2003-07-22
BR0108213A (pt) 2003-03-05
CN101597326B (zh) 2014-07-09
MXPA02007760A (es) 2002-10-23
CN1422278A (zh) 2003-06-04
GB0002952D0 (en) 2000-03-29
NO20023749L (no) 2002-10-07
PL356800A1 (en) 2004-07-12
EP1829889A2 (de) 2007-09-05
DE60130192T2 (de) 2008-05-21
CZ20022740A3 (cs) 2003-01-15
WO2001058934A2 (en) 2001-08-16
CZ304258B6 (cs) 2014-02-05
DK1254162T3 (da) 2008-01-02
CA2399187A1 (en) 2001-08-16
JP5188665B2 (ja) 2013-04-24
NO20023749D0 (no) 2002-08-08
RU2002123877A (ru) 2004-01-10
RU2280039C2 (ru) 2006-07-20
AU783542B2 (en) 2005-11-10
EP1254162A2 (de) 2002-11-06
US7482429B2 (en) 2009-01-27
CA2399187C (en) 2011-04-19
US20040214755A1 (en) 2004-10-28
NO331847B1 (no) 2012-04-23
CN101597326A (zh) 2009-12-09
BG65926B1 (bg) 2010-05-31
HUP0301817A2 (hu) 2003-09-29
CY1106992T1 (el) 2012-09-26
EP2258715A1 (de) 2010-12-08
BG107020A (bg) 2003-05-30
KR100871489B1 (ko) 2008-12-05
IL150981A (en) 2013-05-30
EP1254162B1 (de) 2007-08-29
PT1254162E (pt) 2007-12-03
IL150981A0 (en) 2003-02-12
NZ520488A (en) 2005-03-24
ES2292558T3 (es) 2008-03-16
US20080318849A1 (en) 2008-12-25
HUP0301817A3 (en) 2011-10-28
KR20020092951A (ko) 2002-12-12
PL207121B1 (pl) 2010-11-30
AU3208601A (en) 2001-08-20
EP1829889A3 (de) 2007-09-26
SK11242002A3 (sk) 2003-06-03
WO2001058934A3 (en) 2002-03-21
DE60130192D1 (de) 2007-10-11
HK1047290A1 (en) 2003-02-14
UA76949C2 (en) 2006-10-16

Similar Documents

Publication Publication Date Title
ATE371667T1 (de) Kahalalide f und verwandte verbindungen
DK1161452T3 (da) Kovalent forbundne insulindimerer
ES2127777T3 (es) Uso de compuestos que presentan grupos alcoxisilanos y amino.
AR009742A1 (es) Aminoacidos modificados, medicamentos que contienen estos compuestos y procedimiento para su preparacion
AU9475001A (en) Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
DE60009511D1 (de) Nematizide trifluorbutene
ATE326551T1 (de) Dns-sonde spezifisch für staphylococcus epidermidis
ATE178803T1 (de) Verbindungen und artikel zur geruchsbegrenzung
DE69131589D1 (de) Ribosomen-inaktivierende Proteine, inaktive Vorläuferformen derselben, Verfahren zur Herstellung und eine Methode zur Nutzung
ATE280242T1 (de) Verfahren zum nachweis von bakterien
ATE220420T1 (de) Biokatalytische metoden zum synthetisieren und identifizieren biologisch aktive verbindungen
NL300229I1 (nl) Werkwijze voor het zuiveren van keratinocytgroeifactoren.
DE69027191D1 (de) N-oxygenierte Arylpyrrole als insektizide, akarizide und nematizide Wirkstoffe
DE60142899D1 (de) Verbindungen für den transfer von oligonukleotiden
ATE247085T1 (de) Verbindungen verwendbar zur perhaloalkylierung, reagenz für ihrer durchführung und verfahren zu ihrer herstellung
ATE176803T1 (de) Mikrobielles verfahren zur herstellung von trans- 4-hydroxy-l-prolin
DE69107546T2 (de) Verfahren zur Herstellung von Insektiziden, Akariziden und Nematiziden-2-Aryl-5-(trifluormethyl)-Pyrrolen.
DE60023324D1 (de) Zusammensetzung zur in-vitro befruchtung
DE69306744T2 (de) Verfahren zur Herstellung von 2-aryl-5-trifluoro-methyl Pyrrole-Verbindungen
DE69117438D1 (de) Verfahren zur Herstellung von insektiziden, nematiziden und akariziden, in 4-Stellung substituierten 5-(Trifluormethyl) pyrrol-3-nitril-Verbindungen
ID22910A (id) Metode untuk memproduksi fibrinogen
ATE92077T1 (de) Enzymhemmer und methode zu dessen herstellung.
ATE88474T1 (de) Verfahren zur herstellung eines makrolidderivates.
ECSP972236A (es) Derivados de 6,6- heterobiciclicos sustituidos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1254162

Country of ref document: EP